Back to Discover

LifeStance Health Group, Inc.

LFST · Industry · Nasdaq · As of 10 Sep 2026
55AIR SCORE
  • FundamentalsBalanced
  • ValueWatch
  • News flowBalanced
  • MomentumVery strong
  • SafetyStrong

Overall confidence 78/100 — well-supported by evidence

Discovery Gap: Medium (12/100) · Gap confidence 52/100Some evidence isn't yet fully priced in.

This month at a glance

AIR Score™ change: 0AIR Score™ held steady this month.
Cycle window9 Sep 202610 Sep 2026
MoversNothing moved meaningfully this month.

Evidence timeline

  1. [8-K 8.01] LifeStance Health Group, Inc. — Other EventsSEC · SEC EDGAR
    Aug 6, 2026 · 8-K
  2. [8-K 2.02] LifeStance Health Group, Inc. — Results of Operations and Financial ConditionSEC · SEC EDGAR
    Aug 6, 2026 · 8-K
  3. [8-K 5.02] LifeStance Health Group, Inc. — Departure/Election of Directors or Principal OfficersSEC · SEC EDGAR
    Jul 2, 2026 · 8-K
  4. [8-K 8.01] LifeStance Health Group, Inc. — Other EventsSEC · SEC EDGAR
    May 7, 2026 · 8-K
  5. [8-K 2.02] LifeStance Health Group, Inc. — Results of Operations and Financial ConditionSEC · SEC EDGAR
    May 7, 2026 · 8-K
  6. [8-K 5.02] LifeStance Health Group, Inc. — Departure/Election of Directors or Principal OfficersSEC · SEC EDGAR
    Mar 10, 2026 · 8-K
  7. [8-K 8.01] LifeStance Health Group, Inc. — Other EventsSEC · SEC EDGAR
    Feb 25, 2026 · 8-K
  8. [8-K 5.02] LifeStance Health Group, Inc. — Departure/Election of Directors or Principal OfficersSEC · SEC EDGAR
    Feb 25, 2026 · 8-K
  9. [8-K 2.02] LifeStance Health Group, Inc. — Results of Operations and Financial ConditionSEC · SEC EDGAR
    Feb 25, 2026 · 8-K
  10. [8-K 8.01] LifeStance Health Group, Inc. — Other EventsSEC · SEC EDGAR
    Feb 25, 2026 · 8-K
  11. [8-K 2.02] LifeStance Health Group, Inc. — Results of Operations and Financial ConditionSEC · SEC EDGAR
    Nov 6, 2025 · 8-K
  12. [8-K 5.02] LifeStance Health Group, Inc. — Departure/Election of Directors or Principal OfficersSEC · SEC EDGAR
    Aug 19, 2025 · 8-K

Ask AIR

What would change our view

A weaker balance sheet in the next filing cycle, a material regulatory setback, or a new evidence cluster that re-opens a distance between filings and attention would move the score, and the page would show which one did.

Research, not tips. No buy/sell recommendations, no price forecasts. Every score is derived from public filings and market data — figures round to whole numbers and refresh each trading day.